AcRIS

Эпиднадзор за острыми респираторными заболеваниями (AcRIS)

You are being asked to take part in a study that is sponsored by Pfizer (the “Sponsor”). The Sponsor is providing funding to Ochsner Clinic Foundation to conduct the study. This study is being done completely remotely by using an experimental mobile application downloaded onto your mobile device. This means that you will not have to visit a study site if you choose to take part in this study.

Pfizer is working to better understand if there are voice features that correlate to acute respiratory illness symptoms in particular severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza (flu), and Respiratory Syncytial Virus (RSV). This knowledge may benefit vaccine and therapy development across these and other key disease areas. The data will further characterize self-reported voice and symptom profiles for acute respiratory illness; this may benefit vaccine development across several key disease areas, including influenza and respiratory syncytial virus (RSV) infection.